Akili Labs recruits for ADHD trial with ambitions of FDA clearance for digital medicine
Akili Labs has kicked off open enrollment for a clinical trial of its Project EVO video game platform in a quest to secure for 510(k) clearance from the U.S. Food and Drug Administration for its lead indication — attention deficit hyperactivity disorder. The trial is recruiting at least 300 participants aged 8-12 years old who […]